Stamford, CT -- (SBWIRE) -- 01/10/2014 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: ALTN FUELS AMERICA (OTCMKTS:AFAI), IMD Companies Inc (OTCMKTS:ICBU), Latteno Food Corp (OTCMKTS:LATF), Marina Biotech, Inc. (OTCMKTS:MRNA)
ALTN FUELS AMERICA (OTCMKTS:AFAI) opened the session at $0.12, trading in a range of $0.12 - $0.38. The stock showed a positive performance of +237.50% in the last trading session from its previous close of $0.08 and closed at $0.270. The stock traded on a volume of 7.68 million shares and the average volume of the stock remained 60,975 shares. Alternative Fuels Americas, Inc., a development stage company, intends to operate as a ?seed to pump? biofuels company focusing on Latin America. The company plans to engage in growing plants suitable for conversion into biofuels; extracting crude oils from plant matter; and refining crude oil into international grade biodiesel. It intends to produce biodiesel from various feedstocks, which primarily include Jatropha, as well as algae and coyol.
For How Long AFAI will Fight for Profitability? Read This Trend Analysis report
IMD Companies Inc (OTCMKTS:ICBU) traded 5.83 million shares in the last business day while the average volume of the stock remained 166,434 shares. The stock showed a positive movement of +60.00% to end at $0.0400. The 52 week range of the stock remained $0.004 - $0.078. IMD Companies, Inc., formerly Optimum Mobile Imaging, Corp, is focused on products and services in the health and fitness nutraceutical and medical diagnostics services markets. The Company provides mobile Ultrasound imaging services. It also provides Echocardiography and Vascular Ultrasound services, including Carotid, Arterial with ABI (ankle-brachial index) and Venous duplex ultrasound. The equipment will be transported into customer's facility on a medical cart by its technologist who will perform all tests in one of customer's exam rooms. In February 2011, the Company completed the acquisition of Integrated Medical Diagnostics, Inc. In January 2014, the Company announced that it has formed a partnership with Anything Technologies Media Inc. by acquiring 51% interest in R-Quest Hydroponics, Inc., developer of the environmental master controller for medical and recreational marijuana hydroponic gardens.
For How Long ICBU’s Gloss will Attract Investors? Find out via this report
Latteno Food Corp (OTCMKTS:LATF) reported 834.57 million shares were exchanged during the last trade, while the average volume is about 124.69 million shares. The stock escalated +54.55% and finished the day at $0.0017. The beta of the stock is recorded at -23.54. Latteno Food Corp. (Latteno) is engaged in acquiring, organizing, developing and upgrading companies in the international food and beverage market. Latteno is specializing in the dairy industry and coffee industry. The Company operates through its subsidiary in Brazil. On February 10, 2010 Latteno acquired Global Milk Businesses and Administration of Private Properties Ltda. (Global Milk). Global Milk holds the rights of certain intellectual property of the brand name products manufactured and sold under the brand name Teixeira. In March 2013, the Company acquired Green Cannabis Collective Inc.
For How Long LATF’s Gloss will Attract Investors? Find out via this report
Marina Biotech, Inc. (OTCMKTS:MRNA) shares rose, +52.17 percent from its previous close of $0.46 to close at $0.700. Traded with volume of 1.42 million shares in the prior session and the average volume of the stock remained 138,400 shares. Marina Biotech, Inc. is a biotechnology company focused on the discovery, development and commercialization of nucleic acid-based therapies utilizing gene silencing approaches such as RNA interference (RNAi) and blocking messenger RNA (mRNA) translation. The Company's pipeline includes a clinical program in Familial Adenomatous Polyposis (FAP) and preclinical programs in bladder cancer and myotonic dystrophy. The Company has two liposomal-based delivery platforms.
Why Should Investors Buy MRNA After The Recent Gain? Just Go Here and Find Out
About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.
Read full disclaimer at: http://otcstockpicks.net/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)